Global Peptide Therapeutics Market Size, Manufacturers, Opportunities and Forecast to 2030
Peptides are short chains of amino acid monomers linked by peptide (amide) bonds, the covalent chemical bonds formed when the carboxyl group of one amino acid reacts with the amino group of another.
According to APO Research, The global Peptide Therapeutics market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
Global Peptide Therapeutics key players include Sanofi, Novo Nordisk, Takeda, Eli Lilly, Ipsen, etc. Global top five manufacturers hold a share about 65%.
North America is the largest market, with a share about 55%, followed by Europe and Asia-Pacific, both have a share about 40 percent.
In terms of product, Injection is the largest segment, with a share about 70%. And in terms of application, the largest application is Cancer, followed by Central Nervous System.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Peptide Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peptide Therapeutics.
The Peptide Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Peptide Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, gross margin by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Peptide Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Peptide Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Peptide Therapeutics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2019-2024, 2025-2030). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Peptide Therapeutics companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
Chapter 12: Concluding Insights of the report
According to APO Research, The global Peptide Therapeutics market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
Global Peptide Therapeutics key players include Sanofi, Novo Nordisk, Takeda, Eli Lilly, Ipsen, etc. Global top five manufacturers hold a share about 65%.
North America is the largest market, with a share about 55%, followed by Europe and Asia-Pacific, both have a share about 40 percent.
In terms of product, Injection is the largest segment, with a share about 70%. And in terms of application, the largest application is Cancer, followed by Central Nervous System.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Peptide Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peptide Therapeutics.
The Peptide Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Peptide Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, gross margin by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Sanofi
- Teva
- Novo Nordisk
- Takeda
- Eli Lilly
- AstraZeneca
- Novartis
- AbbVie
- Ipsen
- Ferring
- Merck
- The Medicines
- J & J
- Injection
- Oral
- Other
- Cancer
- Metabolic Disorders
- Central Nervous System
- Other
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Peptide Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Peptide Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Peptide Therapeutics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2019-2024, 2025-2030). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Peptide Therapeutics companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
Chapter 12: Concluding Insights of the report
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Market Growth Prospects
1.3 Global Peptide Therapeutics Market Size Overview by Region 2019 VS 2023 VS 2030
1.4 Global Peptide Therapeutics Market Size by Region (2019-2030)
1.4.1 Global Peptide Therapeutics Market Size by Region (2019-2024)
1.4.2 Global Peptide Therapeutics Market Size by Region (2025-2030)
1.5 Key Regions Peptide Therapeutics Market Size (2019-2030)
1.5.1 North America Peptide Therapeutics Market Size Growth Rate (2019-2030)
1.5.2 Europe Peptide Therapeutics Market Size Growth Rate (2019-2030)
1.5.3 Asia-Pacific Peptide Therapeutics Market Size Growth Rate (2019-2030)
1.5.4 Latin America Peptide Therapeutics Market Size Growth Rate (2019-2030)
1.5.5 Middle East & Africa Peptide Therapeutics Market Size Growth Rate (2019-2030)
2 PEPTIDE THERAPEUTICS MARKET BY TYPE
2.1 Type Introduction
2.1.1 Injection
2.1.2 Oral
2.1.3 Other
2.2 Global Peptide Therapeutics Market Size by Type
2.2.1 Global Peptide Therapeutics Market Size Overview by Type (2019-2030)
2.2.2 Global Peptide Therapeutics Historic Market Size Review by Type (2019-2024)
2.2.3 Global Peptide Therapeutics Market Size Forecasted by Type (2025-2030)
2.3 Global Peptide Therapeutics Market Size by Regions
2.3.1 North America Peptide Therapeutics Market Size Breakdown by Type (2019-2024)
2.3.2 Europe Peptide Therapeutics Market Size Breakdown by Type (2019-2024)
2.3.3 Asia-Pacific Peptide Therapeutics Market Size Breakdown by Type (2019-2024)
2.3.4 Latin America Peptide Therapeutics Market Size Breakdown by Type (2019-2024)
2.3.5 Middle East and Africa Peptide Therapeutics Market Size Breakdown by Type (2019-2024)
3 PEPTIDE THERAPEUTICS MARKET BY APPLICATION
3.1 Type Introduction
3.1.1 Cancer
3.1.2 Metabolic Disorders
3.1.3 Central Nervous System
3.1.4 Other
3.2 Global Peptide Therapeutics Market Size by Application
3.2.1 Global Peptide Therapeutics Market Size Overview by Application (2019-2030)
3.2.2 Global Peptide Therapeutics Historic Market Size Review by Application (2019-2024)
3.2.3 Global Peptide Therapeutics Market Size Forecasted by Application (2025-2030)
3.3 Global Peptide Therapeutics Market Size by Regions
3.3.1 North America Peptide Therapeutics Market Size Breakdown by Application (2019-2024)
3.3.2 Europe Peptide Therapeutics Market Size Breakdown by Application (2019-2024)
3.3.3 Asia-Pacific Peptide Therapeutics Market Size Breakdown by Application (2019-2024)
3.3.4 Latin America Peptide Therapeutics Market Size Breakdown by Application (2019-2024)
3.3.5 Middle East and Africa Peptide Therapeutics Market Size Breakdown by Application (2019-2024)
4 GLOBAL MARKET DYNAMICS
4.1 Peptide Therapeutics Industry Trends
4.2 Peptide Therapeutics Industry Drivers
4.3 Peptide Therapeutics Industry Opportunities and Challenges
4.4 Peptide Therapeutics Industry Restraints
5 COMPETITIVE INSIGHTS BY COMPANY
5.1 Global Top Players by Peptide Therapeutics Revenue (2019-2024)
5.2 Global Peptide Therapeutics Industry Company Ranking, 2022 VS 2023 VS 2024
5.3 Global Peptide Therapeutics Key Company Headquarters & Area Served
5.4 Global Peptide Therapeutics Company, Product Type & Application
5.5 Global Peptide Therapeutics Company Commercialization Time
5.6 Market Competitive Analysis
5.6.1 Global Peptide Therapeutics Market CR5 and HHI
5.6.2 Global Top 5 and 10 Peptide Therapeutics Players Market Share by Revenue in 2023
5.6.3 2023 Peptide Therapeutics Tier 1, Tier 2, and Tier
6 COMPANY PROFILES
6.1 Sanofi
6.1.1 Sanofi Comapny Information
6.1.2 Sanofi Business Overview
6.1.3 Sanofi Peptide Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.1.4 Sanofi Peptide Therapeutics Product Portfolio
6.1.5 Sanofi Recent Developments
6.2 Teva
6.2.1 Teva Comapny Information
6.2.2 Teva Business Overview
6.2.3 Teva Peptide Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.2.4 Teva Peptide Therapeutics Product Portfolio
6.2.5 Teva Recent Developments
6.3 Novo Nordisk
6.3.1 Novo Nordisk Comapny Information
6.3.2 Novo Nordisk Business Overview
6.3.3 Novo Nordisk Peptide Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.3.4 Novo Nordisk Peptide Therapeutics Product Portfolio
6.3.5 Novo Nordisk Recent Developments
6.4 Takeda
6.4.1 Takeda Comapny Information
6.4.2 Takeda Business Overview
6.4.3 Takeda Peptide Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.4.4 Takeda Peptide Therapeutics Product Portfolio
6.4.5 Takeda Recent Developments
6.5 Eli Lilly
6.5.1 Eli Lilly Comapny Information
6.5.2 Eli Lilly Business Overview
6.5.3 Eli Lilly Peptide Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.5.4 Eli Lilly Peptide Therapeutics Product Portfolio
6.5.5 Eli Lilly Recent Developments
6.6 AstraZeneca
6.6.1 AstraZeneca Comapny Information
6.6.2 AstraZeneca Business Overview
6.6.3 AstraZeneca Peptide Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.6.4 AstraZeneca Peptide Therapeutics Product Portfolio
6.6.5 AstraZeneca Recent Developments
6.7 Novartis
6.7.1 Novartis Comapny Information
6.7.2 Novartis Business Overview
6.7.3 Novartis Peptide Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.7.4 Novartis Peptide Therapeutics Product Portfolio
6.7.5 Novartis Recent Developments
6.8 AbbVie
6.8.1 AbbVie Comapny Information
6.8.2 AbbVie Business Overview
6.8.3 AbbVie Peptide Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.8.4 AbbVie Peptide Therapeutics Product Portfolio
6.8.5 AbbVie Recent Developments
6.9 Ipsen
6.9.1 Ipsen Comapny Information
6.9.2 Ipsen Business Overview
6.9.3 Ipsen Peptide Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.9.4 Ipsen Peptide Therapeutics Product Portfolio
6.9.5 Ipsen Recent Developments
6.10 Ferring
6.10.1 Ferring Comapny Information
6.10.2 Ferring Business Overview
6.10.3 Ferring Peptide Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.10.4 Ferring Peptide Therapeutics Product Portfolio
6.10.5 Ferring Recent Developments
6.11 Merck
6.11.1 Merck Comapny Information
6.11.2 Merck Business Overview
6.11.3 Merck Peptide Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.11.4 Merck Peptide Therapeutics Product Portfolio
6.11.5 Merck Recent Developments
6.12 The Medicines
6.12.1 The Medicines Comapny Information
6.12.2 The Medicines Business Overview
6.12.3 The Medicines Peptide Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.12.4 The Medicines Peptide Therapeutics Product Portfolio
6.12.5 The Medicines Recent Developments
6.13 J & J
6.13.1 J & J Comapny Information
6.13.2 J & J Business Overview
6.13.3 J & J Peptide Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.13.4 J & J Peptide Therapeutics Product Portfolio
6.13.5 J & J Recent Developments
7 NORTH AMERICA
7.1 North America Peptide Therapeutics Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2 North America Peptide Therapeutics Market Size by Country (2019-2024)
7.3 North America Peptide Therapeutics Market Size Forecast by Country (2025-2030)
8 EUROPE
8.1 Europe Peptide Therapeutics Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2 Europe Peptide Therapeutics Market Size by Country (2019-2024)
8.3 Europe Peptide Therapeutics Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Peptide Therapeutics Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2 Asia-Pacific Peptide Therapeutics Market Size by Country (2019-2024)
9.3 Asia-Pacific Peptide Therapeutics Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA
10.1 Latin America Peptide Therapeutics Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2 Latin America Peptide Therapeutics Market Size by Country (2019-2024)
10.3 Latin America Peptide Therapeutics Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Peptide Therapeutics Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2 Middle East & Africa Peptide Therapeutics Market Size by Country (2019-2024)
11.3 Middle East & Africa Peptide Therapeutics Market Size Forecast by Country (2025-2030)
12 CONCLUDING INSIGHTS
13 APPENDIX
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources
1.1 Product Definition
1.2 Global Market Growth Prospects
1.3 Global Peptide Therapeutics Market Size Overview by Region 2019 VS 2023 VS 2030
1.4 Global Peptide Therapeutics Market Size by Region (2019-2030)
1.4.1 Global Peptide Therapeutics Market Size by Region (2019-2024)
1.4.2 Global Peptide Therapeutics Market Size by Region (2025-2030)
1.5 Key Regions Peptide Therapeutics Market Size (2019-2030)
1.5.1 North America Peptide Therapeutics Market Size Growth Rate (2019-2030)
1.5.2 Europe Peptide Therapeutics Market Size Growth Rate (2019-2030)
1.5.3 Asia-Pacific Peptide Therapeutics Market Size Growth Rate (2019-2030)
1.5.4 Latin America Peptide Therapeutics Market Size Growth Rate (2019-2030)
1.5.5 Middle East & Africa Peptide Therapeutics Market Size Growth Rate (2019-2030)
2 PEPTIDE THERAPEUTICS MARKET BY TYPE
2.1 Type Introduction
2.1.1 Injection
2.1.2 Oral
2.1.3 Other
2.2 Global Peptide Therapeutics Market Size by Type
2.2.1 Global Peptide Therapeutics Market Size Overview by Type (2019-2030)
2.2.2 Global Peptide Therapeutics Historic Market Size Review by Type (2019-2024)
2.2.3 Global Peptide Therapeutics Market Size Forecasted by Type (2025-2030)
2.3 Global Peptide Therapeutics Market Size by Regions
2.3.1 North America Peptide Therapeutics Market Size Breakdown by Type (2019-2024)
2.3.2 Europe Peptide Therapeutics Market Size Breakdown by Type (2019-2024)
2.3.3 Asia-Pacific Peptide Therapeutics Market Size Breakdown by Type (2019-2024)
2.3.4 Latin America Peptide Therapeutics Market Size Breakdown by Type (2019-2024)
2.3.5 Middle East and Africa Peptide Therapeutics Market Size Breakdown by Type (2019-2024)
3 PEPTIDE THERAPEUTICS MARKET BY APPLICATION
3.1 Type Introduction
3.1.1 Cancer
3.1.2 Metabolic Disorders
3.1.3 Central Nervous System
3.1.4 Other
3.2 Global Peptide Therapeutics Market Size by Application
3.2.1 Global Peptide Therapeutics Market Size Overview by Application (2019-2030)
3.2.2 Global Peptide Therapeutics Historic Market Size Review by Application (2019-2024)
3.2.3 Global Peptide Therapeutics Market Size Forecasted by Application (2025-2030)
3.3 Global Peptide Therapeutics Market Size by Regions
3.3.1 North America Peptide Therapeutics Market Size Breakdown by Application (2019-2024)
3.3.2 Europe Peptide Therapeutics Market Size Breakdown by Application (2019-2024)
3.3.3 Asia-Pacific Peptide Therapeutics Market Size Breakdown by Application (2019-2024)
3.3.4 Latin America Peptide Therapeutics Market Size Breakdown by Application (2019-2024)
3.3.5 Middle East and Africa Peptide Therapeutics Market Size Breakdown by Application (2019-2024)
4 GLOBAL MARKET DYNAMICS
4.1 Peptide Therapeutics Industry Trends
4.2 Peptide Therapeutics Industry Drivers
4.3 Peptide Therapeutics Industry Opportunities and Challenges
4.4 Peptide Therapeutics Industry Restraints
5 COMPETITIVE INSIGHTS BY COMPANY
5.1 Global Top Players by Peptide Therapeutics Revenue (2019-2024)
5.2 Global Peptide Therapeutics Industry Company Ranking, 2022 VS 2023 VS 2024
5.3 Global Peptide Therapeutics Key Company Headquarters & Area Served
5.4 Global Peptide Therapeutics Company, Product Type & Application
5.5 Global Peptide Therapeutics Company Commercialization Time
5.6 Market Competitive Analysis
5.6.1 Global Peptide Therapeutics Market CR5 and HHI
5.6.2 Global Top 5 and 10 Peptide Therapeutics Players Market Share by Revenue in 2023
5.6.3 2023 Peptide Therapeutics Tier 1, Tier 2, and Tier
6 COMPANY PROFILES
6.1 Sanofi
6.1.1 Sanofi Comapny Information
6.1.2 Sanofi Business Overview
6.1.3 Sanofi Peptide Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.1.4 Sanofi Peptide Therapeutics Product Portfolio
6.1.5 Sanofi Recent Developments
6.2 Teva
6.2.1 Teva Comapny Information
6.2.2 Teva Business Overview
6.2.3 Teva Peptide Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.2.4 Teva Peptide Therapeutics Product Portfolio
6.2.5 Teva Recent Developments
6.3 Novo Nordisk
6.3.1 Novo Nordisk Comapny Information
6.3.2 Novo Nordisk Business Overview
6.3.3 Novo Nordisk Peptide Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.3.4 Novo Nordisk Peptide Therapeutics Product Portfolio
6.3.5 Novo Nordisk Recent Developments
6.4 Takeda
6.4.1 Takeda Comapny Information
6.4.2 Takeda Business Overview
6.4.3 Takeda Peptide Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.4.4 Takeda Peptide Therapeutics Product Portfolio
6.4.5 Takeda Recent Developments
6.5 Eli Lilly
6.5.1 Eli Lilly Comapny Information
6.5.2 Eli Lilly Business Overview
6.5.3 Eli Lilly Peptide Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.5.4 Eli Lilly Peptide Therapeutics Product Portfolio
6.5.5 Eli Lilly Recent Developments
6.6 AstraZeneca
6.6.1 AstraZeneca Comapny Information
6.6.2 AstraZeneca Business Overview
6.6.3 AstraZeneca Peptide Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.6.4 AstraZeneca Peptide Therapeutics Product Portfolio
6.6.5 AstraZeneca Recent Developments
6.7 Novartis
6.7.1 Novartis Comapny Information
6.7.2 Novartis Business Overview
6.7.3 Novartis Peptide Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.7.4 Novartis Peptide Therapeutics Product Portfolio
6.7.5 Novartis Recent Developments
6.8 AbbVie
6.8.1 AbbVie Comapny Information
6.8.2 AbbVie Business Overview
6.8.3 AbbVie Peptide Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.8.4 AbbVie Peptide Therapeutics Product Portfolio
6.8.5 AbbVie Recent Developments
6.9 Ipsen
6.9.1 Ipsen Comapny Information
6.9.2 Ipsen Business Overview
6.9.3 Ipsen Peptide Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.9.4 Ipsen Peptide Therapeutics Product Portfolio
6.9.5 Ipsen Recent Developments
6.10 Ferring
6.10.1 Ferring Comapny Information
6.10.2 Ferring Business Overview
6.10.3 Ferring Peptide Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.10.4 Ferring Peptide Therapeutics Product Portfolio
6.10.5 Ferring Recent Developments
6.11 Merck
6.11.1 Merck Comapny Information
6.11.2 Merck Business Overview
6.11.3 Merck Peptide Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.11.4 Merck Peptide Therapeutics Product Portfolio
6.11.5 Merck Recent Developments
6.12 The Medicines
6.12.1 The Medicines Comapny Information
6.12.2 The Medicines Business Overview
6.12.3 The Medicines Peptide Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.12.4 The Medicines Peptide Therapeutics Product Portfolio
6.12.5 The Medicines Recent Developments
6.13 J & J
6.13.1 J & J Comapny Information
6.13.2 J & J Business Overview
6.13.3 J & J Peptide Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.13.4 J & J Peptide Therapeutics Product Portfolio
6.13.5 J & J Recent Developments
7 NORTH AMERICA
7.1 North America Peptide Therapeutics Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2 North America Peptide Therapeutics Market Size by Country (2019-2024)
7.3 North America Peptide Therapeutics Market Size Forecast by Country (2025-2030)
8 EUROPE
8.1 Europe Peptide Therapeutics Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2 Europe Peptide Therapeutics Market Size by Country (2019-2024)
8.3 Europe Peptide Therapeutics Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Peptide Therapeutics Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2 Asia-Pacific Peptide Therapeutics Market Size by Country (2019-2024)
9.3 Asia-Pacific Peptide Therapeutics Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA
10.1 Latin America Peptide Therapeutics Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2 Latin America Peptide Therapeutics Market Size by Country (2019-2024)
10.3 Latin America Peptide Therapeutics Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Peptide Therapeutics Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2 Middle East & Africa Peptide Therapeutics Market Size by Country (2019-2024)
11.3 Middle East & Africa Peptide Therapeutics Market Size Forecast by Country (2025-2030)
12 CONCLUDING INSIGHTS
13 APPENDIX
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources
